• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Hester Biosciences Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting

    12-11-2025 | 11:29 am

    Hester Biosciences announced Q2 & H1 FY26 consolidated results. H1 Profit after Tax surged 99% to ₹31.63 Cr, with revenue at ₹155.07 Cr. Q2 PAT rose 71% to ₹14.33 Cr. They also received market authorisation for the H9N2 vaccine, boosting future exports.

    No comments yet. Be the first to comment!

    All announcements from Hester Biosciences Limited